Terumo Corporation
Terumo Corporation TRUMY Peers
See (TRUMY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TRUMY | $18.21 | +0.05% | 27.2B | 33.11 | $0.55 | +0.32% |
| SRTOY | $22.04 | N/A | 214.4B | 91.83 | $0.24 | +0.30% |
| ESLOY | $143.03 | -0.31% | 131.9B | 48.82 | $2.93 | +1.36% |
| ESLOF | $284.25 | -0.26% | 131.4B | 48.59 | $5.85 | +1.35% |
| MECNY | $88.63 | N/A | 107.8B | N/A | N/A | N/A |
| SOAGY | $47.65 | -0.23% | 74.1B | 148.91 | $0.32 | +0.16% |
| HOCPF | $121.10 | +8.23% | 41.2B | 29.32 | $4.13 | +0.89% |
| HOCPY | $118.50 | +0.65% | 40.6B | 29.55 | $4.01 | +0.43% |
| RSMDF | $22.00 | N/A | 27B | 24.72 | $0.89 | +0.84% |
| TRUMF | $18.18 | -8.84% | 26.8B | 33.05 | $0.55 | +1.00% |
Stock Comparison
TRUMY vs SRTOY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SRTOY has a market cap of 214.4B. Regarding current trading prices, TRUMY is priced at $18.21, while SRTOY trades at $22.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SRTOY's P/E ratio is 91.83. In terms of profitability, TRUMY's ROE is +0.07%, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ESLOY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ESLOY has a market cap of 131.9B. Regarding current trading prices, TRUMY is priced at $18.21, while ESLOY trades at $143.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ESLOY's P/E ratio is 48.82. In terms of profitability, TRUMY's ROE is +0.07%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ESLOF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ESLOF has a market cap of 131.4B. Regarding current trading prices, TRUMY is priced at $18.21, while ESLOF trades at $284.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ESLOF's P/E ratio is 48.59. In terms of profitability, TRUMY's ROE is +0.07%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MECNY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, MECNY has a market cap of 107.8B. Regarding current trading prices, TRUMY is priced at $18.21, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas MECNY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, TRUMY is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SOAGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SOAGY has a market cap of 74.1B. Regarding current trading prices, TRUMY is priced at $18.21, while SOAGY trades at $47.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SOAGY's P/E ratio is 148.91. In terms of profitability, TRUMY's ROE is +0.07%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to SOAGY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HOCPF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, HOCPF has a market cap of 41.2B. Regarding current trading prices, TRUMY is priced at $18.21, while HOCPF trades at $121.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas HOCPF's P/E ratio is 29.32. In terms of profitability, TRUMY's ROE is +0.07%, compared to HOCPF's ROE of +0.15%. Regarding short-term risk, TRUMY is less volatile compared to HOCPF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HOCPY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, HOCPY has a market cap of 40.6B. Regarding current trading prices, TRUMY is priced at $18.21, while HOCPY trades at $118.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas HOCPY's P/E ratio is 29.55. In terms of profitability, TRUMY's ROE is +0.07%, compared to HOCPY's ROE of +0.15%. Regarding short-term risk, TRUMY is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs RSMDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, RSMDF has a market cap of 27B. Regarding current trading prices, TRUMY is priced at $18.21, while RSMDF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas RSMDF's P/E ratio is 24.72. In terms of profitability, TRUMY's ROE is +0.07%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, TRUMY is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TRUMF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TRUMF has a market cap of 26.8B. Regarding current trading prices, TRUMY is priced at $18.21, while TRUMF trades at $18.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TRUMF's P/E ratio is 33.05. In terms of profitability, TRUMY's ROE is +0.07%, compared to TRUMF's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CLPBY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CLPBY has a market cap of 22.2B. Regarding current trading prices, TRUMY is priced at $18.21, while CLPBY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CLPBY's P/E ratio is 31.45. In terms of profitability, TRUMY's ROE is +0.07%, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, TRUMY is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SDMHF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SDMHF has a market cap of 22B. Regarding current trading prices, TRUMY is priced at $18.21, while SDMHF trades at $225.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SDMHF's P/E ratio is 94.07. In terms of profitability, TRUMY's ROE is +0.07%, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to SDMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAUHY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SAUHY has a market cap of 21.3B. Regarding current trading prices, TRUMY is priced at $18.21, while SAUHY trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SAUHY's P/E ratio is 38.20. In terms of profitability, TRUMY's ROE is +0.07%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, TRUMY is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAUHF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SAUHF has a market cap of 21.2B. Regarding current trading prices, TRUMY is priced at $18.21, while SAUHF trades at $133.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SAUHF's P/E ratio is 38.24. In terms of profitability, TRUMY's ROE is +0.07%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, TRUMY is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CLPBF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CLPBF has a market cap of 21.1B. Regarding current trading prices, TRUMY is priced at $18.21, while CLPBF trades at $93.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CLPBF's P/E ratio is 30.30. In terms of profitability, TRUMY's ROE is +0.07%, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, TRUMY is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SARTF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SARTF has a market cap of 15.4B. Regarding current trading prices, TRUMY is priced at $18.21, while SARTF trades at $200.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SARTF's P/E ratio is 126.61. In terms of profitability, TRUMY's ROE is +0.07%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SARTF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OCPNF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, OCPNF has a market cap of 15.2B. Regarding current trading prices, TRUMY is priced at $18.21, while OCPNF trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas OCPNF's P/E ratio is 18.75. In terms of profitability, TRUMY's ROE is +0.07%, compared to OCPNF's ROE of +0.10%. Regarding short-term risk, TRUMY is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SUVPF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SUVPF has a market cap of 14.9B. Regarding current trading prices, TRUMY is priced at $18.21, while SUVPF trades at $259.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SUVPF's P/E ratio is 163.94. In terms of profitability, TRUMY's ROE is +0.07%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to SUVPF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SSSGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SSSGY has a market cap of 14.8B. Regarding current trading prices, TRUMY is priced at $18.21, while SSSGY trades at $42.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SSSGY's P/E ratio is 137.13. In terms of profitability, TRUMY's ROE is +0.07%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs FSPKF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, FSPKF has a market cap of 12.1B. Regarding current trading prices, TRUMY is priced at $18.21, while FSPKF trades at $20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas FSPKF's P/E ratio is 53.08. In terms of profitability, TRUMY's ROE is +0.07%, compared to FSPKF's ROE of +0.10%. Regarding short-term risk, TRUMY is less volatile compared to FSPKF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SSMXY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SSMXY has a market cap of 10.4B. Regarding current trading prices, TRUMY is priced at $18.21, while SSMXY trades at $16.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SSMXY's P/E ratio is 27.72. In terms of profitability, TRUMY's ROE is +0.07%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, TRUMY is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SSMXF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SSMXF has a market cap of 9.2B. Regarding current trading prices, TRUMY is priced at $18.21, while SSMXF trades at $14.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SSMXF's P/E ratio is 24.55. In terms of profitability, TRUMY's ROE is +0.07%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, TRUMY is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CNVVY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CNVVY has a market cap of 8.2B. Regarding current trading prices, TRUMY is priced at $18.21, while CNVVY trades at $16.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CNVVY's P/E ratio is 43.27. In terms of profitability, TRUMY's ROE is +0.07%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, TRUMY is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CNVVF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CNVVF has a market cap of 7.3B. Regarding current trading prices, TRUMY is priced at $18.21, while CNVVF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CNVVF's P/E ratio is 40.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, TRUMY is more volatile compared to CNVVF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CZMWY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CZMWY has a market cap of 6.3B. Regarding current trading prices, TRUMY is priced at $18.21, while CZMWY trades at $72.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CZMWY's P/E ratio is 35.67. In terms of profitability, TRUMY's ROE is +0.07%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to CZMWY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CZMWF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CZMWF has a market cap of 6.1B. Regarding current trading prices, TRUMY is priced at $18.21, while CZMWF trades at $69.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CZMWF's P/E ratio is 34.49. In terms of profitability, TRUMY's ROE is +0.07%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs YPHDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, YPHDF has a market cap of 5.7B. Regarding current trading prices, TRUMY is priced at $18.21, while YPHDF trades at $417.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas YPHDF's P/E ratio is 53.45. In terms of profitability, TRUMY's ROE is +0.07%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, TRUMY is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs FLMNF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, FLMNF has a market cap of 5.4B. Regarding current trading prices, TRUMY is priced at $18.21, while FLMNF trades at $64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas FLMNF's P/E ratio is 28.96. In terms of profitability, TRUMY's ROE is +0.07%, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, TRUMY is more volatile compared to FLMNF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs FLMNY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, FLMNY has a market cap of 5.4B. Regarding current trading prices, TRUMY is priced at $18.21, while FLMNY trades at $12.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas FLMNY's P/E ratio is 29.09. In terms of profitability, TRUMY's ROE is +0.07%, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, TRUMY is less volatile compared to FLMNY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ADDLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, TRUMY is priced at $18.21, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, TRUMY's ROE is +0.07%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs AHICF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, AHICF has a market cap of 4.4B. Regarding current trading prices, TRUMY is priced at $18.21, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas AHICF's P/E ratio is 59.89. In terms of profitability, TRUMY's ROE is +0.07%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to AHICF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SHWGF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SHWGF has a market cap of 3.4B. Regarding current trading prices, TRUMY is priced at $18.21, while SHWGF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SHWGF's P/E ratio is 12.67. In terms of profitability, TRUMY's ROE is +0.07%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, TRUMY is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TEVNF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TEVNF has a market cap of 3.2B. Regarding current trading prices, TRUMY is priced at $18.21, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TEVNF's P/E ratio is -0.21. In terms of profitability, TRUMY's ROE is +0.07%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, TRUMY is more volatile compared to TEVNF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ANSLY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ANSLY has a market cap of 2.9B. Regarding current trading prices, TRUMY is priced at $18.21, while ANSLY trades at $80.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ANSLY's P/E ratio is 24.54. In terms of profitability, TRUMY's ROE is +0.07%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, TRUMY is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TCHBF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TCHBF has a market cap of 2.7B. Regarding current trading prices, TRUMY is priced at $18.21, while TCHBF trades at $211.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TCHBF's P/E ratio is 32.80. In terms of profitability, TRUMY's ROE is +0.07%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to TCHBF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ANSLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ANSLF has a market cap of 2.6B. Regarding current trading prices, TRUMY is priced at $18.21, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, TRUMY's ROE is +0.07%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, TRUMY is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TCGGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, TRUMY is priced at $18.21, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TCGGY's P/E ratio is 27.91. In terms of profitability, TRUMY's ROE is +0.07%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs EKTAY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, EKTAY has a market cap of 2B. Regarding current trading prices, TRUMY is priced at $18.21, while EKTAY trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas EKTAY's P/E ratio is 85.17. In terms of profitability, TRUMY's ROE is +0.07%, compared to EKTAY's ROE of +0.10%. Regarding short-term risk, TRUMY is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GRRMF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, GRRMF has a market cap of 1.9B. Regarding current trading prices, TRUMY is priced at $18.21, while GRRMF trades at $55.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas GRRMF's P/E ratio is 21.36. In terms of profitability, TRUMY's ROE is +0.07%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs EKTAF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, EKTAF has a market cap of 1.9B. Regarding current trading prices, TRUMY is priced at $18.21, while EKTAF trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas EKTAF's P/E ratio is 86.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to EKTAF's ROE of +0.10%. Regarding short-term risk, TRUMY is less volatile compared to EKTAF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BOEUF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, BOEUF has a market cap of 1.8B. Regarding current trading prices, TRUMY is priced at $18.21, while BOEUF trades at $27.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas BOEUF's P/E ratio is 146.34. In terms of profitability, TRUMY's ROE is +0.07%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, TRUMY is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TGLVY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TGLVY has a market cap of 1.6B. Regarding current trading prices, TRUMY is priced at $18.21, while TGLVY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TGLVY's P/E ratio is 79.97. In terms of profitability, TRUMY's ROE is +0.07%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, TRUMY is more volatile compared to TGLVY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs NPRRF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, TRUMY is priced at $18.21, while NPRRF trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas NPRRF's P/E ratio is 44.74. In terms of profitability, TRUMY's ROE is +0.07%, compared to NPRRF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to NPRRF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TDVXF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TDVXF has a market cap of 1.2B. Regarding current trading prices, TRUMY is priced at $18.21, while TDVXF trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TDVXF's P/E ratio is 70.63. In terms of profitability, TRUMY's ROE is +0.07%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, TRUMY is more volatile compared to TDVXF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BITGF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, TRUMY is priced at $18.21, while BITGF trades at $14.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas BITGF's P/E ratio is 45.06. In terms of profitability, TRUMY's ROE is +0.07%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, TRUMY is more volatile compared to BITGF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs PBHDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, PBHDF has a market cap of 1.1B. Regarding current trading prices, TRUMY is priced at $18.21, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, TRUMY's ROE is +0.07%, compared to PBHDF's ROE of +0.06%. Regarding short-term risk, TRUMY is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs KSRBF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, KSRBF has a market cap of 866.4M. Regarding current trading prices, TRUMY is priced at $18.21, while KSRBF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, TRUMY's ROE is +0.07%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, TRUMY is less volatile compared to KSRBF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs NNCSF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, NNCSF has a market cap of 804.5M. Regarding current trading prices, TRUMY is priced at $18.21, while NNCSF trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas NNCSF's P/E ratio is 88.33. In terms of profitability, TRUMY's ROE is +0.07%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SHWGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SHWGY has a market cap of 788.6M. Regarding current trading prices, TRUMY is priced at $18.21, while SHWGY trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SHWGY's P/E ratio is 11.16. In terms of profitability, TRUMY's ROE is +0.07%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, TRUMY is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SPMXF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SPMXF has a market cap of 550.3M. Regarding current trading prices, TRUMY is priced at $18.21, while SPMXF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SPMXF's P/E ratio is -18.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, TRUMY is more volatile compared to SPMXF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs JNDOF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, TRUMY is priced at $18.21, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, TRUMY's ROE is +0.07%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, TRUMY is less volatile compared to JNDOF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HGYMF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, HGYMF has a market cap of 524.8M. Regarding current trading prices, TRUMY is priced at $18.21, while HGYMF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas HGYMF's P/E ratio is 33.81. In terms of profitability, TRUMY's ROE is +0.07%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, TRUMY is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAFLY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SAFLY has a market cap of 449.6M. Regarding current trading prices, TRUMY is priced at $18.21, while SAFLY trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SAFLY's P/E ratio is 223.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to SAFLY's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CLHLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, TRUMY is priced at $18.21, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, TRUMY's ROE is +0.07%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, TRUMY is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAFLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SAFLF has a market cap of 306.5M. Regarding current trading prices, TRUMY is priced at $18.21, while SAFLF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SAFLF's P/E ratio is 12.67. In terms of profitability, TRUMY's ROE is +0.07%, compared to SAFLF's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GUERF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, TRUMY is priced at $18.21, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas GUERF's P/E ratio is 8.19. In terms of profitability, TRUMY's ROE is +0.07%, compared to GUERF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TSNLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TSNLF has a market cap of 252.4M. Regarding current trading prices, TRUMY is priced at $18.21, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, TRUMY's ROE is +0.07%, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, TRUMY is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OPSSF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, TRUMY is priced at $18.21, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, TRUMY's ROE is +0.07%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, TRUMY is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MCDA Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, MCDA has a market cap of 212M. Regarding current trading prices, TRUMY is priced at $18.21, while MCDA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas MCDA's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to MCDA's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to MCDA. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs EEOIF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, TRUMY is priced at $18.21, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, TRUMY's ROE is +0.07%, compared to EEOIF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs UEEC Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, UEEC has a market cap of 30.9M. Regarding current trading prices, TRUMY is priced at $18.21, while UEEC trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas UEEC's P/E ratio is -12.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, TRUMY is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GVDI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, GVDI has a market cap of 16.2M. Regarding current trading prices, TRUMY is priced at $18.21, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas GVDI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TUTH Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, TUTH has a market cap of 12.2M. Regarding current trading prices, TRUMY is priced at $18.21, while TUTH trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas TUTH's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to TUTH's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OTCFF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, OTCFF has a market cap of 12.1M. Regarding current trading prices, TRUMY is priced at $18.21, while OTCFF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas OTCFF's P/E ratio is -14.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to OTCFF's ROE of +18.74%. Regarding short-term risk, TRUMY is more volatile compared to OTCFF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OJSY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, OJSY has a market cap of 9.1M. Regarding current trading prices, TRUMY is priced at $18.21, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas OJSY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to OJSY's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to OJSY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs IMTH Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, IMTH has a market cap of 8.1M. Regarding current trading prices, TRUMY is priced at $18.21, while IMTH trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas IMTH's P/E ratio is -0.44. In terms of profitability, TRUMY's ROE is +0.07%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, TRUMY is more volatile compared to IMTH. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs YBGJ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, YBGJ has a market cap of 7.7M. Regarding current trading prices, TRUMY is priced at $18.21, while YBGJ trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas YBGJ's P/E ratio is -3.21. In terms of profitability, TRUMY's ROE is +0.07%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, TRUMY is less volatile compared to YBGJ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BLMHF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, TRUMY is priced at $18.21, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, TRUMY's ROE is +0.07%, compared to BLMHF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CBSC Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CBSC has a market cap of 5M. Regarding current trading prices, TRUMY is priced at $18.21, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CBSC's P/E ratio is -4.41. In terms of profitability, TRUMY's ROE is +0.07%, compared to CBSC's ROE of +1.52%. Regarding short-term risk, TRUMY is more volatile compared to CBSC. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs RSCF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, RSCF has a market cap of 4.8M. Regarding current trading prices, TRUMY is priced at $18.21, while RSCF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas RSCF's P/E ratio is -5.65. In terms of profitability, TRUMY's ROE is +0.07%, compared to RSCF's ROE of +0.08%. Regarding short-term risk, TRUMY is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs PXMVF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, TRUMY is priced at $18.21, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, TRUMY's ROE is +0.07%, compared to PXMVF's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ECIA Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ECIA has a market cap of 4.4M. Regarding current trading prices, TRUMY is priced at $18.21, while ECIA trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ECIA's P/E ratio is -9.25. In terms of profitability, TRUMY's ROE is +0.07%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, TRUMY is less volatile compared to ECIA. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs NSTGQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, TRUMY is priced at $18.21, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs PDMI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, TRUMY is priced at $18.21, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas PDMI's P/E ratio is -0.01. In terms of profitability, TRUMY's ROE is +0.07%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, TRUMY is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs REMI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, REMI has a market cap of 200K. Regarding current trading prices, TRUMY is priced at $18.21, while REMI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas REMI's P/E ratio is -1.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to REMI's ROE of -0.08%. Regarding short-term risk, TRUMY is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs WHSI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, TRUMY is priced at $18.21, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas WHSI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, TRUMY is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BLFE Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, TRUMY is priced at $18.21, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas BLFE's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to BLFE. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs QTXB Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, TRUMY is priced at $18.21, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas QTXB's P/E ratio is -0.05. In terms of profitability, TRUMY's ROE is +0.07%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CEOS Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, CEOS has a market cap of 117.4K. Regarding current trading prices, TRUMY is priced at $18.21, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas CEOS's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, TRUMY is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SVSO Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SVSO has a market cap of 63.8K. Regarding current trading prices, TRUMY is priced at $18.21, while SVSO trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SVSO's P/E ratio is -0.17. In terms of profitability, TRUMY's ROE is +0.07%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, TRUMY is less volatile compared to SVSO. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs LANZ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, LANZ has a market cap of 27.7K. Regarding current trading prices, TRUMY is priced at $18.21, while LANZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas LANZ's P/E ratio is 1.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, TRUMY is more volatile compared to LANZ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GMVDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, TRUMY is priced at $18.21, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas GMVDF's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, TRUMY is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs VSMD Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, VSMD has a market cap of 22.4K. Regarding current trading prices, TRUMY is priced at $18.21, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas VSMD's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, TRUMY is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ASFX Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ASFX has a market cap of 17.5K. Regarding current trading prices, TRUMY is priced at $18.21, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ASFX's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, TRUMY is more volatile compared to ASFX. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MDIT Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, MDIT has a market cap of 17.2K. Regarding current trading prices, TRUMY is priced at $18.21, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas MDIT's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, TRUMY is less volatile compared to MDIT. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs INND Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, INND has a market cap of 15.9K. Regarding current trading prices, TRUMY is priced at $18.21, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas INND's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to INND's ROE of +0.32%. Regarding short-term risk, TRUMY is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs LFPI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, LFPI has a market cap of 10.2K. Regarding current trading prices, TRUMY is priced at $18.21, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas LFPI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, TRUMY is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SECI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SECI has a market cap of 9.2K. Regarding current trading prices, TRUMY is priced at $18.21, while SECI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SECI's P/E ratio is -0.18. In terms of profitability, TRUMY's ROE is +0.07%, compared to SECI's ROE of -0.00%. Regarding short-term risk, TRUMY is less volatile compared to SECI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs DGEN Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, TRUMY is priced at $18.21, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas DGEN's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SEYE Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, TRUMY is priced at $18.21, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SEYE's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to SEYE's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BGMD Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, TRUMY is priced at $18.21, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas BGMD's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to BGMD. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ADLI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, TRUMY is priced at $18.21, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas ADLI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, TRUMY is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HRAL Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, HRAL has a market cap of 446. Regarding current trading prices, TRUMY is priced at $18.21, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas HRAL's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, TRUMY is less volatile compared to HRAL. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SDCCQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, SDCCQ has a market cap of 403. Regarding current trading prices, TRUMY is priced at $18.21, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, TRUMY is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MICRD Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, MICRD has a market cap of 317. Regarding current trading prices, TRUMY is priced at $18.21, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas MICRD's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, TRUMY is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs RGBOQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, TRUMY is priced at $18.21, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs VTEQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, TRUMY is priced at $18.21, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.07%, compared to VTEQ's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OCPNY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 27.2B. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, TRUMY is priced at $18.21, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 33.11, whereas OCPNY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.07%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, TRUMY is more volatile compared to OCPNY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.